1.020000 CAD
0.06
5.56%
Last update Dec 18, 3:59 PM EST
Market closed
Day range
1.020000
1.070000
Previous close
1.080000
Open
1.070000
Access this stock data via API
Subscribe
Medicenna Therapeutics Corp.
1.02
0.06
5.56%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 14.4M 10.8M 9.3M 14.7M
Selling general and admin 5.9M 7.9M 7.0M 7.7M
Other operating expenses
Operating income -20.4M -18.7M -16.3M -22.5M
Non operating interest income
Income 1.4M 1.2M 914K 69K
Expense
Other income expense 7.3M -8.0M 5.3M -173K
Pretax income -11.8M -25.5M -10.0M -22.6M
Tax provision
Net income -11.8M -25.5M -10.0M -22.6M
Basic EPS -0.2 -0.4 -0.2 -0.4
Diluted EPS -0.2 -0.4 -0.2 -0.4
Basic average shares 76.7M 69.6M 64.7M 54.3M
Diluted average shares 76.7M 69.6M 64.7M 54.3M
EBITDA -27.6M -10.7M -21.6M -22.3M
Net income from continuing op. -11.8M -25.5M -10.0M -22.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 14 hours 36 minutes

17:23
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/Toronto timezone (EST, UTC-05:00).